Actively Recruiting
Integrative Multi-Omics and Non-Coding RNA Profiling in Heart Failure Patients The BIOCARDIUM-HF Study by University of Zurich
Led by University of Zurich · Updated on 2026-09-25
500
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating heart failure by combining detailed clinical evaluations with advanced molecular profiling techniques, including transcriptomics, epigenomics, and proteomics. The study focuses on identifying molecular markers such as non-coding RNAs that relate to the onset and progression of heart failure. This observational research aims to deepen the understanding of heart failure by integrating clinical data with multi-omics analysis. Participants are grouped based on their heart function measured by left ventricular ejection fraction reduced <40%, mildly reduced 40%-50%, and preserved >50%. The study collects biological samples for molecular profiling and gathers clinical information including advanced imaging, hemodynamic assessments, and biomarker analysis. These efforts aim to identify potential biomarkers that predict disease progression and highlight new targets for future therapies. Throughout the study, participants undergo clinical evaluations and provide biological samples for molecular analysis. Researchers will monitor outcomes such as death from any cause and heart failure hospitalizations over up to five years following enrollment. The study involves ongoing follow-up visits to collect data and assess disease progression, contributing to a comprehensive understanding of heart failure in diverse patient groups.
CONDITIONS
Brief Title
Molecular Underpinnings of Heart Failure, Integrative Multi-Omics, and Non-Coding RNA Profiling
Research Team
J
Jan A Kleeberger, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here